Jeffrey Leroy Larson
CIK: 0002064985
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Tvardi Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Apr 17, 2025TVRD
Tvardi Therapeutics, Inc.
Award(A)DirectEmployee Stock Option (right to buy)
10.8K shares- - Apr 15, 2025TVRD
Tvardi Therapeutics, Inc.
Award(A)DirectEmployee Stock Option (right to buy)
16.8K shares- - Apr 15, 2025TVRD
Tvardi Therapeutics, Inc.
Award(A)DirectEmployee Stock Option (right to buy)
5.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 17, 2025 | TVRD Tvardi Therapeutics, Inc. | Award(A) Employee Stock Option (right to buy) | 10,820 | - | - | Direct |
| Apr 15, 2025 | TVRD Tvardi Therapeutics, Inc. | Award(A) Employee Stock Option (right to buy) | 16,764 | - | - | Direct |
| Apr 15, 2025 | TVRD Tvardi Therapeutics, Inc. | Award(A) Employee Stock Option (right to buy) | 5,364 | - | - | Direct |
1-3 of 3 transactions
About Larson Jeffrey Leroy
Larson Jeffrey Leroy (SEC CIK 0002064985) files insider reports with the SEC as SVP, Research & Development of Tvardi Therapeutics, Inc. (TVRD).
Signal8 holds 3 ownership filings by Larson Jeffrey Leroy (1 Form 3, 2 Form 4), filed between Apr 17, 2025 and Apr 21, 2025. Those filings report 3 transactions, from Apr 15, 2025 to Apr 17, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Larson Jeffrey Leroy's filings is in SUGAR LAND, TX.
Recent filings by Larson Jeffrey Leroy
Other insiders filing for Tvardi Therapeutics, Inc. (TVRD)
- Shiff Susan Ph.D., Director
- Smith Cynthia, Director
- Shah Sujal, Director
- HALL WALLACE L JR, Director
- WYZGA MICHAEL S, Director
- O'Brien Stephen Paul, Principal Accounting Officer